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Abstract: For many years, epidemiological studies continued to suggest that high fat diets are linked to an 
increased incidence of certain cancers. However, whether the oncogenic properties of fat are associated with 
their quantity rather than the quality has become debatable. Epidemiological studies have been suggesting 
that n-6 polyunsaturated fatty acids (n-6 PUFA) and saturated fats are more likely to increase the incidence of 
cancer, whereas monounsaturated fatty acids (MUFA) and n-3 polyunsaturated fatty acids (n-3 PUFA) are 
more likely to prevent or decrease the chance of carcinogenesis. A firm conclusion cannot be drawn yet 
because of insufficient research. This paper reviews the current knowledge of the effects of saturated fats, 
different types of unsaturated fats, and fat-soluble vitamins on the etiology of cancer. 
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Background 
For more than fifty years dietary fats have been 
known to play a substantial role in the etiology of 
cancer [1]. Dietary habits seem to be more easily 
modified than tobacco smoking cessation or 
physical exercise habits [2]. Different studies have 
suggested that a high consumption of fat is related 
to an increased incidence of breast, colon, 
pancreatic and prostate cancer [1]. However, this 
finding is no longer accepted because the 
oncogenic properties of fat are independent of 
their caloric content. Much research has indicated 
that dietary intake of monounsaturated fats, (e.g. 
olive oil) [1, 3] or n-3 PUFA (e.g. fish oil, flaxseed 
oil) [4-6] is inversely correlated with the 
development of colorectal cancer. It has also been 
documented that diets high in animal fat and n-6 
PUFA contribute to an increased risk of colorectal 
[7], colon [8] and breast cancer [9].  
The mechanism by which dietary n-3 and n-6 
PUFA protect or enhance tumor development, 
respectively, has not been fully investigated, but 
most of the proposed mechanisms are based on 
the metabolic fate of these fats and the 
subsequent biosynthesis of eicosanoids, which 
exert control over several systems. Fats, 
particularly saturated fats, may affect hormonal 
status, modify cell membrane structure and 
function, cell signaling transduction pathways, and 
gene expression, and they may even modulate 
functions of the immune system [10]. It has 
become necessary to determine the roles of fatty 
acids in the development of or protection against 
human cancer. This article will discuss the 
relationship between cancer on the one hand, and 
dietary saturated fats and various types of 
unsaturated fats on the other hand, as well as 
indicate the mechanisms by which different fatty 
acids induce or prevent carcinogenesis. 
 
1. Saturated  Fats 
During the past several decades, it has been 
shown that high intake of saturated fat, animal fat, 
and meat is associated with an increased risk of 
colorectal [11] and breast cancer [12]. These 
findings are supported by studies that compared 
risk factors for colon and rectal cancer and 
showed that dietary animal fat may be associated 
with increased risk of colon cancer [13-15]. 
However,  a large cohort study followed 483,109 
men and 619,199 women over 14 years failed to 
link meat consumption to increased risk of 
pancreatic cancer [16]. Another prospective study 
found that saturated fat intake and butter 
consumption were strongly correlated with an 
increased risk of pancreatic cancer, whereas 
energy and carbohydrate intake were inversely 
proportional to development of pancreatic cancer 
[17]. Additionally, a multiethnic cohort study 
showed a 50% increase in pancreatic cancer risk 
with diets that were high in pork or total red meat 
but no increased risk was found with dietary intake 
of poultry, fish, dairy products, eggs, saturated fat 
or cholesterol [18]. This study indicated that 
mutagenic compounds produced during the 
cooking or preservation of food could be the link 
between consumption of red or processed meat 
and the increased risk of pancreatic cancer. 
Although burned and singed meat contains high 
concentrations of carcinogens and mutagens, a 
clear link to increased rates of cancer has not 
been found [19].  
A study published in 2007 compared the 
incidence of colorectal cancer between African 
Americans (n=17), Native Africans (n=18), and 
Caucasian Africans (n=17).  It found that higher 
risks of colorectal cancer and mucosal 
proliferation rates were associated with higher 
dietary intake of animal products and with larger 
colonic populations of bacteria producing 
potentially toxic hydrogen and secondary bile-salts 
[20].  
In one animal study, 120 male F344 rats were 
injected weekly with azoxymethane, a carcinogen, 
and fed a high-fat diet containing 20% mixed lipids 
(HFML). Treatment with HFML for 38 weeks was 
significantly associated with increased colonic 
aberrant crypt foci (ACF), early putative 
preneoplastic lesions of colon neoplasia, 
increased cyclooxygenase-2 activity (COX-2) and 
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suppressed colonic apoptosis [21]. This large-
scale study was the first to show the effect of 
HFML on colonic carcinogenesis in a well-
established animal model. However, these data 
failed to elucidate how the HFML diet induces 
tumor formation in the colon.  
In another similar study, F344/N rats were fed a 
diet containing 19% animal fat (beef tallow) and 
exposed for 26 weeks to tribromomethane (TBM), 
a drinking water contaminant. A significant and 
nearly two-fold expansion in ACF was observed in 
animals whose diets were high in fat compared to 
those fed a normal diet [22].  
The mechanisms by which fats promote 
tumorigenesis are not fully understood. However, 
current knowledge indicates that a high fat intake 
results in increased production of bile acid, which 
is converted by intestinal bacteria into secondary 
bile acid and cytotoxic compounds. These 
compounds may enhance the proliferative activity 
of the colonic epithelium [1, 20, and 23] by 
increasing ornithine decarboxylase, which is 
involved in cell division. They also seem to speed 
up secondary cellular transduction signals, such 
as protein kinase C, and modify membrane fluidity 
by changing the phospholipid composition of the 
cell membrane, prostaglandin metabolism, and 
local inflammatory responses, along with 
increasing COX-2 activity and decreasing 
apoptosis [21, 23-25].  
It has been suggested that diets rich in meat and 
other animal products may be low in plant foods, 
such as fruits, vegetables, and whole grain cereals 
[26]. Thus, such diets may have a lower content of 
certain anti-carcinogenic compounds, such as 
antioxidants and phytoestrogens or other 
phytochemicals that exhibit some antiproliferative 
activity [27, 28]. 
 
2.  Monounsaturated Fatty Acids 
Great effort has been made to clarify the 
association between consumption of MUFA, 
particularly oleic acid, and breast-cancer risk. Oils 
that are rich in MUFA, particularly olive oil, are 
considered to be the healthiest type of fat. To 
corroborate the protective role of olive oil by 
showing a decreased risk of cancer, a case-control 
study was conducted between 1999 and 2001 on 
755 women: 291 cases with breast cancer and 
464 controls. It was found that the consumption of 
≥ 8.8 g of olive oil per day significantly correlated 
with a lower risk of breast cancer [29]. In 
agreement with these observations, a case-control 
study conducted in Greece showed that the 
increased intake of olive oil was associated with a 
lower risk of breast cancer [30]. Likewise, 
Galeone, et al., conducted a multicenter case-
control study in Italy and Switzerland between 
1992 and 2000 on 1394 colon cancer patients, 
886 rectal cancer patients, and 4765 controls. 
Their findings demonstrated that olive oil might 
decrease colon cancer risk but not rectal cancer 
risk [31].  
Olive oil has been shown to reduce the risk not 
only of breast and colon cancer, but of many other 
neoplasms as well. In one case control study, 754 
individuals with initial primary cancer in the oral 
cavity and pharynx, together with 1775 controls, 
were followed between 1992 and 1997 [32]. It was 
found that consumption of 0.7 g of olive oil daily 
was associated with a lower risk of oral cancer 
[32]. In contrast, Elahi, et al., did not observe a 
protective effect of olive oil against development of 
breast cancer [33].  
In general, the mechanisms underlying the 
protective role of olive oil against cancer seem to 
rely on the polyphenolic compounds, the 
tocopherol content of olive oil, and its fatty acid 
structure, which prevents free radical-initiated 
peroxidation. Moreover, Romero, et al., 
demonstrated in vitro that these substances exert 
a strong bactericidal activity against eight strains 
of Helicobacter pylori (the primary cause of peptic, 
gastric, and duodenal ulcers). Among these 
phenolic compounds, the dialdehydic form of 
decarboxymethyl ligstroside aglycon exhibited the 
strongest bactericidal effect at a concentration as 
low as 1.3 µg/ml. These results raise the 
possibility of considering virgin olive oil a chemo-
preventive agent for peptic ulcer and gastric 
cancer [34]. Furthermore, it was hypothesized that 
olive oil may regulate cancer-related oncogenes. 
Colomer, et al., showed that exogenous 
supplementation of cultured breast cancer cells 
with physiological concentrations of oleic acid 
(OA) significantly reduced the overexpression of 
HER2 (Her-2/neu, erbB-2), a well-characterized 
oncogene playing a key role in the etiology and 
progression of breast carcinomas [35].  
  
3.  n-3 and n-6 Polyunsaturated Fatty Acids ( 
n-3 PUFA) 
Several studies have associated high intake of 
n-6 fatty acids (e.g. corn and safflower oils) with a 
poor outcome in cancer patients [36, 37], whereas 
high consumption of n-3 fatty acids (e.g. fish and 
flaxseed oils) has been linked to a favorable 
outcome [38, 39]. To confirm these observations, 
30 patients with colorectal adenomas were 
randomly placed in a control group or in a 
treatment group receiving a highly purified 
eicosapentaenoic acid (EPA) in free fatty acid 
form (2 g/day).  After three months of treatment, 
crypt cell proliferation was reduced and apoptosis 
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was increased in normal colonic mucosa of the 
EPA-treated group as compared to the control 
group [40]. The authors suggested that 
metabolism of EPA may lead to the production of 
3-series prostaglandins, such as PGE3, which 
have an inhibiting effect on cell proliferation and 
COX-2 activity, along with reduction in the 
mucosal levels of n-6 fatty acid. However, this 
study did not provide any further insight into the 
mechanism by which n-3 fatty acids such as EPA 
elevate mucosal colonic apoptosis [40]. On the 
contrary, Cheng, et al., showed that EPA and 
docosahexaenoic acid (DHA) supplementation 
significantly increased the production of the 
apoptosis-enhancing protein Bax, indicating that 
upregulation of Bax protein within normal mucosa 
could be one mechanism by which EPA increases 
mucosal apoptosis in the colon [41].  
The ameliorative influence of n-3 fatty acids on 
cancer has also been documented in animal 
studies. Twenty male F344 rats were fed either 
high fat fish oil (HFFO) or high fat corn oil (HFCO) 
diets for 8 weeks and injected with azoxymethane 
(AOM)-induced colonic aberrant crypt foci (ACF). 
Rats fed the HFFO diet had a lower incidence of 
AOM-induced ACF in the proximal colon than rats 
fed the HFCO diet. In addition, the activity of 
hepatic glutathione s-transferase (GST), an 
antioxidant enzyme, and plasma levels of PGE-2, 
one of the primary prostaglandins formed from the 
metabolism of AA, were significantly reduced in 
rats fed the HFFO diet relative to those fed the 
HFCO diet. This study indicated that HFFO diets 
could compromise the antioxidant status of the cell 
by augmenting lipid peroxidation [42].  Flaxseed oil 
(FO) is a good source of n-3 fatty acids. 
Supplementing AIN 93G diet with 10% and 20% of 
flaxseed meal (FSM) or 7% and 14% of FO 
decreased the incidence of AOM-induced ACF in 
Fisher 344 male rats [43]. n-3 PUFA may hinder 
carcinogenesis by a molecular mechanism, such 
as increased or decreased production of free 
radicals and reactive oxygen species, repression 
of AA-derived eicosanoid synthesis, attenuation 
the expression of vascular cell adhesion molecule 
(VCAM-1), believed to promote the adhesion of 
circulating tumor cells to the endothelium, 
influences on transcription factor activity and 
signal transduction pathways, modification of 
estrogen metabolism, and mechanisms involving 
insulin sensitivity and membrane fluidity, as 
reviewed [9].  
In general, n-6 PUFA appear to possess some 
carcinogenic properties. However, conjugated 
linoleic acid (CLA), a naturally occurring n-6 fatty 
acid found primarily in ruminant meat and dairy 
products, has been demonstrated to protect 
against cancer in animal models of chemical 
carcinogenesis and to inhibit the proliferation of 
human cancer cell lines [44]. Different 
mechanisms may be suggested for how CLA 
inhibits carcinogenesis. First, it is incorporated into 
the cell membrane as oleic acid and metabolized 
as linoleic acid, influencing linoleic acid 
desaturation and elongation. Thereby, it 
modulates prostaglandin metabolism. Second, it 
can decrease synthesis of insulin-like growth 
factor (IGF) II and down-regulate extracellular 
signal-regulated kinase-1/2 pathway and IGF-I 
receptor signaling [45]. Third, CLA may increase 
free retinol levels by enhancing the level of cellular 
retinol-binding protein (CRBP) mediated by 
activation of peroxisome proliferator-activated 
receptor (PPAR)-alpha (PPAR-alpha), known to 
be a transcription factor for CRBP [46]. In addition, 
CLA, particularly the t10c12 isomer, suppresses 
cell proliferation, and induces apoptosis and 
expression of the pro-apoptotic gene nonsteroidal 
anti-inflammatory drug-activated gene 1 in human 
colorectal cancer cells [47]. Furthermore, there are 
indications that CLA may inhibit growth of cancer 
cells through induction of cyclin-dependent kinase 
inhibitor p21CIP1/WAF1, a tumor suppressor 
protein [48]. 
 
4. Fat-soluble  vitamins 
There are four families of fat-soluble vitamins: A, 
D, E, and K. These vitamins have been studied in 
animals and in humans to assess their influence 
on the growth of cancer cells of different origins. 
Ohlsson, et al, studied the effect of fat-soluble 
vitamins on seven cell lines that were obtained 
from patients with pancreatic adenocarcinoma. 
They found that the number of pancreatic cancer 
cells decreased after treatment with vitamin A and 
D analogues, especially when high concentrations 
were used. However, combining retinoids with the 
vitamin D analogue EB 1089 did not enhance its 
effect. Moreover, vitamin E succinate repressed 
cell growth in three out of seven cell lines, 
whereas vitamin K1 increased the number of 
pancreatic cancer cells in three out of seven cell 
lines. This study concluded that high 
concentrations of vitamin A and D analogues 
attenuated the cell numbers in pancreatic cancer 
cell lines, whereas vitamins E succinate and K1 
had little if any effect [49]. Vitamin K analogues 
have also been shown to inhibit cancer cell growth 
through increased protein kinase phosphorylation, 
a process important in modulation of cellular 
transduction signals [50].  
Vitamin E has been linked to inhibition of the 
growth of cancer cells [51] as well as to inhibition 
of UV-induced DNA damage and carcinogenesis 
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in animal models [52], probably by enhancing the 
glutathione-dependent enzyme system [53]. 
Following a secondary analysis of the α-
tocopherol, Beta-Carotene Cancer Prevention 
Study (ATBC), it was reported that male smokers 
who daily received 50 µg of vitamin E (α-
tocopherol) had a 41% decline in prostate cancer 
mortality and a 36% decline in its incidence [54]. In 
the same line, a large epidemiologic cohort study 
found that daily intake of 100 µg vitamin E by 
smokers and those who had recently quit smoking 
reduced the risk of metastatic or fatal prostate 
cancer by 44% compared with others who did not 
receive the vitamin E supplement [55]. 
Similarly, high values of serum provitamin A and 
carotenoids were associated with low risks of 
mortality from lung, stomach, colorectal and liver 
cancer among a group of Japanese aged from 39 
to 85 years and followed for 11.7 years [56]. 
Vitamin A may attenuate carcinogenesis through 
its essential role in controlling cell proliferation and 
differentiation [57]. Taken together, mechanisms 
underlying the protective effect of fat-soluble 
vitamins remain uncertain. However, the 
antioxidant properties of some vitamins and their 
ability to induce apoptosis may play a significant 
role in prevention or inhibition of cancer cell 
growth, respectively. Retinol and provitamin A 
carotenoids may also decrease cancer risk 
through other mechanisms, such as inducing 
cellular differentiation [58]. 
 
Conclusion 
The studies described here and elsewhere 
indicate that monounsaturated fat, n-3 PUFA, and 
fat soluble vitamins may have a profound influence 
on the prevention and/or suppression of cancer, 
whereas saturated fat and n-6 PUFA may increase 
the risk of carcinogenesis. Monounsaturated fat 
and n-3 fatty acids should be preferred over 
animal fats and other vegetable fats in the diet. 
Inconsistency in the literature with regards to the 
impact of n-3 PUFA on cancer might be due to a) 
the frequent lack of proper design in studies on 
humans, b) the supplement dose is often too low 
or too high, c) inability to define the target 
populations due to collection of insufficient data 
from the participants, so that they may not 
adequately represent the target populations of 
interest, d) inadequate sample size. Further 
studies are needed to determine the inductive or 
protective mechanisms of dietary fats on 
carcinogenesis in well-designed human studies.  
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